Fivetran Launches Hybrid Deployment, Enabling Enterprises to Run Pipelines in Any Environment on a Unified Platform
Hybrid Deployment offers a secure, flexible solution for seamless data movement across environments
Fivetran, the global leader in data movement, today announced Hybrid Deployment, a new solution that allows customers to securely run data pipelines within their own environment from the Fivetran managed platform, providing a single control plane to manage all data sources, whether they are cloud-based SaaS apps or legacy databases with data that needs to be tightly controlled and managed for regulatory or compliance purposes. With the industry’s most comprehensive selection of connectors, destinations and features, Fivetran empowers enterprises to centralize data efficiently, reliably and securely, while supporting governance and compliance requirements and benefiting from 24/7 support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240918100338/en/
Introducing Fivetran’s Hybrid Deployment: A fully managed service that meets the highest enterprise security standards. (Graphic: Business Wire)
Enterprises with sensitive data or in regulated industries often struggle to build data-driven practices. Seamless data access is critical for boosting efficiency, enabling AI-powered analytics and producing reliable data products. Centralizing data can lead to complex, costly systems that burden engineering teams. Traditional SaaS tools often lack the needed control and security, forcing organizations into more cumbersome solutions. DIY or self-hosted solutions often fail to scale effectively, especially as data priorities evolve in the age of AI, resulting in inefficiencies and an urgent need for modernization. Fivetran’s Hybrid Deployment simplifies this by enabling businesses to securely centralize their data and prepare it for AI and machine learning, all while maintaining control over sensitive information.
"Introducing a hybrid cloud deployment model to the Fivetran platform opens up entirely new possibilities for businesses of all sizes," said George Fraser, Fivetran CEO. "Businesses no longer have to choose between managed automation and data control. They can now securely move data from all their critical sources—like Salesforce, Workday, Oracle, SAP, other cloud and on-premises databases and ERPs—into a data warehouse or data lake, all while keeping that data under their own control. This is especially valuable for industries like healthcare and life sciences and financial services, where secure, compliant and reliable data is critical."
How Hybrid Deployment works
Hybrid Deployment keeps sensitive data within the customer’s environment while taking advantage of Fivetran’s management and monitoring tools. A lightweight local connector securely moves the data, while Fivetran’s user-friendly interface makes configuration and monitoring simple, all from a single control plane.
"Fivetran's new hybrid deployment option is a game-changer. Now customers can easily centralize all their data, regardless of security or compliance requirements, given the ability to separate the control and data plane,” said Vinay Kumar Katta, Managing Delivery Architect, Capgemini. “Customers will appreciate Fivetran's best-in-class platform that offers the flexibility to choose how and where their pipelines run. We're excited to advance our partnership with Fivetran and help more enterprises modernize their data infrastructure."
The separate control and data plane architecture ensures data never leaves the customer’s secure environment, giving them ultimate control over how their data is moved while still benefiting from Fivetran’s managed platform. This solution automates and centralizes the data movement process, while also giving enterprises the benefits of:
- Full visibility: Monitor all pipelines from a single interface.
- Data security: Control access, mask sensitive data and track movement to ensure compliance.
- Compatibility across environments: Works across AWS, Microsoft Azure, Google Cloud, and on-premises environments.
- Simple setup: Quick installation with no complex maintenance required.
- Flexibility: Scale and customize pipelines with integrations for APIs and tools like Terraform.
- Cost management: Track usage and control budgets with detailed reporting tools.
"phData is excited about Fivetran's new Hybrid Deployment option, which allows our customers in regulated industries like healthcare, life sciences and financial services to scale the configuration and ingestion of highly sensitive datasets on self-managed infrastructure," said Troy Fokken, Chief Architect at phData. "This approach streamlines the data pipeline processes, as customers don't need to self-host software or build DIY pipelines to securely move data from source systems to destination."
As government regulations like GDPR, HIPAA and CCPA continue to tighten, and new ones emerge, enterprises are increasingly focused on ensuring their data practices meet strict security and compliance standards. Recent breaches in healthcare and financial services have highlighted the risks of exposing sensitive information and compromising critical systems. DIY or self-managed pipelines can introduce vulnerabilities, especially as teams must frequently make updates in order to meet rapidly changing data schema, which increases the risk of errors that can lead to data breaches. Fivetran’s Hybrid Deployment mitigates these risks by providing a managed solution that runs within the customer’s secure environment, ensuring compliance while eliminating common points of failure.
“The simplicity of management is the best value of Hybrid Deployment,” said Ajay Bidani, Data and Insights Manager at Powell Industries. “I know the status of our pipelines and can launch and manage cloud-based and on-premises pipelines directly from one platform. Given our history with on-premises applications, I can say that pipelines going down and requiring restart was quite cumbersome, but Hybrid Deployment has been considerably different. I can realize the ease of monitoring and maintaining pipelines with immediacy. The ability to quickly stand up Hybrid Deployment for on-premises data movement, while managing it from a straightforward and familiar cloud-based control plane, is a great value add.”
Reducing complexity for engineering teams
Hybrid Deployment reduces manual setup and maintenance, allowing engineering teams to focus on building data-driven solutions. Fivetran handles the heavy lifting, helping businesses extract value from their data without worrying about brittle DIY infrastructure. A recent report by IDC found that enterprises can realize an average annual productivity gain of $1.5 million by transitioning to Fivetran’s managed data movement solution.
Fivetran’s data integration platform can handle high-volume change data capture from databases and offers 600+ pre-built connectors for a range of SaaS applications, events, files, ERPs, data warehouses and data lakes. The Fivetran platform replicates data with minimal impact on source systems, low latency and high throughput, making it the trusted choice for over 6,300 customers globally. With the richest technical feature set of any data ingestion tool, Fivetran meets the widest range of data integration use cases.
To learn more, visit the Fivetran blog or explore images and assets in the Fivetran newsroom. You can also start your free Hybrid Deployment trial today at Fivetran.com.
About Fivetran
Fivetran, the global leader in data movement, helps customers use their data to power everything from AI applications and ML models, to predictive analytics and operational workloads. The Fivetran platform reliably and securely centralizes data from hundreds of SaaS applications and databases into any cloud destination — whether deployed on-premises, in the cloud or in a hybrid environment. Thousands of global brands, including Autodesk, Condé Nast, JetBlue and Morgan Stanley, trust Fivetran to move their most valuable data assets to fuel analytics, drive operational efficiencies and power innovation. For more info, visit fivetran.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240918100338/en/
Contacts
Matias Cavallin
Matias Cavallin
323-715-0020
matias.cavallin@fivetran.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK™,a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press release
- ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not responsive to other CFTR modulator therapies - - In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and further decreased sweat chloride compared to TRIKAFTA® - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and t
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press release
- Approximately 300 more people with cystic fibrosis in the U.S. are now eligible for a medicine that treats the underlying cause of their disease for the first time - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
Andersen Global udvider sin ekspertise med tilføjelsen af Valora20.12.2024 17:07:00 CET | Pressemeddelelse
Andersen Global fortsætter sin udvidelse af servicetilbud gennem en samarbejdsaftale med Valora, der er en uafhængig virksomhed med speciale i levering af skræddersyede løsninger til både private og institutionelle kunder globalt. Valora har kontorer i Miami og Raleigh og desuden global tilstedeværelse i Den Dominikanske Republik, Storbritannien og Caymanøerne. Valora blev grundlagt i 2011 af partneren Luis de Leon og tilbyder et stort udvalg af tjenester, blandt andet værdiansættelse, performance, regnskab og administration, global enhedsstyring, fondsvirksomhed og andre skræddersyede løsninger. "Et samarbejde med Andersen passer godt til både vores kunder og vores team," siger Luis. "Synergierne mellem for vores servicetilbud vil sætte os i stand til at levere omfattende og integrerede løsninger med stadigt stigende global rækkevidde." Global Chairman og CEO for Andersen Mark L. Vorsatz udtaler: "Valoras team og virksomhedskultur er, sammen med deres fokus på det praktiske, et godt m
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom